Login to Your Account



Actavis drops China to focus on other markets, sells local operations to Chiral

By Shannon Ellis
Staff Writer

Wednesday, January 29, 2014

SHANGHAI – The world’s third largest maker of generics, Actavis plc, has backed out of China, citing risks and a difficult business environment.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription